Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope.
Alleva DG; Maki RA; Putnam AL; Robinson JM; Kipnes MS; Dandona P; Marks JB; Simmons DL; Greenbaum CJ; Jimenez RG; Conlon PJ; Gottlieb PA; Scandinavian Journal Of Immunology, 2006, vol. 63, issue 1, p 59, ISSN 03009475. ISBN 03009475.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef